Clinical Effect and Mechanism of Heat-clearing and Phlegm-resolving Recipe in the Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease (Phlegm Heat and Phlegm Turbidity in Lungs)_West China Medical Journal

Authors：

 JIANGHong-li ¹ , ZHOUWei ² , MINJie ¹ ,  MAOBing ¹

1. Department of Integrated Traditional Chinese Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, P. R. China;
2. Department of Respiratory Medicine, Chengdu First People's Hospital, Chengdu, Sichuan 610041, P. R. China;

Corresponding?author：

MAOBing, Email: maobing@medmail.com.cn

Keywords：

Chronic obstructive pulmonary disease; Chinese heat-clearing and phlegm-resolving recipe; Interleukin-8; Interleukin-10; Bactericidal/permeability increasing protein

DOI：

10.7507/1002-0179.20150258

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Objective To investigate the clinical effect and mechanism of Chinese heat-clearing and phlegm-resolving recipe in the treatment of acute exacerbation of chronic obstructive pulmonary disease (AECOPD). Methods A randomized controlled trial (RCT) was conducted. A total of sixty in-patients with AECOPD of phlegm heat and phlegm turbidity in lungs were randomly allocated to treatment group and control group with an equal number of patients between October 2009 and March 2010. The treatment duration was 10 days. Symptom scores of traditional Chinese medicine (TCM), pulmonary function, white blood cell count, polymorphonuclear neutrophils, C-reactive protein and the plasma concentration of bactericidal/permeability increasing protein (BPI) and interleukin (IL)-8 and IL-10 were detected. Results For TCM syndrome of phlegm heat and phlegm turbidity, there was a statistical difference between the two groups after treatment (P<0.05). Cough, sputum amount, expectoration and coated tongue were improved obviously in the treatment group (P<0.05). The total explicit efficiency rate and effective rate were 56.0% and 84.0% in the control group and 82.1% and 92.9% in the treatment group respectively. The total explicit efficiency rate was significantly different between the two groups (P<0.05), while the total effective rate was not significantly different (P>0.05). Plasma concentration of IL-8 decreased markedly in the treatment group and IL-10 and BPI increased obviously. There was no significant difference in the change of BPI, IL-8 between the two groups (P>0.05), except for IL-10 (P<0.05). Conclusion Chinese heat-clearing and phlegm-resolving recipe can improve signs and symptoms of TCM in the treatment of AECOPD (phlegm heat and phlegm turbidity in lungs), by the potential mechanism of increasing the level of IL-10.

Citation： JIANGHong-li, ZHOUWei, MINJie, MAOBing. Clinical Effect and Mechanism of Heat-clearing and Phlegm-resolving Recipe in the Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease (Phlegm Heat and Phlegm Turbidity in Lungs). West China Medical Journal, 2015, 30(5): 905-910. doi: 10.7507/1002-0179.20150258 Copy

1.	Lopez AD, Murray CC. The global burden of disease, 1990-2020[J]. Nature Med, 1998, 4(11):1241-1243.
2.	World Health Organization. The global burden of disease:2004 update[R/OL].[2015-02-01]. http://www.who.int/healthinfo/global_burden_disease/2004_report_update/en/.
3.	Fuhrman C, Delmas MC. Epidemiology of chronic obstructive pulmonary disease in France[J]. Rev Mal Respir, 2010, 27(2):160-168.
4.	Caballero A, Torres-Duque CA, Jaramillo C. Prevalence of COPD in five Colombian cities situated at low, medium, and high altitude (PREPOCOL study)[J]. Chest, 2008, 133(2):343-349.
5.	Greskevitch M, Kullman G, Bang KM. Respiratory disease in agricultural workers:mortality and morbidity statistics[J]. J Agromedicine, 2008, 12(3):5-10.
6.	Halbert RJ, Natoli JL, Gano A, et al. Global burden of COPD:systematic review and meta-analysis[J]. Eur Respir J, 2006, 28(3):523-532.
7.	Vestbo J, Hurd SS, Agustí AG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease:GOLD executive summary[J]. Am J Respir Crit Care Med, 2013, 187(4):347-65.
8.	中華醫學會呼吸病學分會. 慢性阻塞性肺疾病診治指南(2007年修訂版)[J]. 中華結核與呼吸雜志, 2007, 30(1):8-17.
9.	鄭筱萸. 中藥新藥臨床研究指導原則(試行)[M]. 北京:中國醫藥科技出版社, 2002:54-58.
10.	李文, 毛兵, 王剛, 等. 從氣道炎癥和氣道黏液高分泌泌研究清熱化痰法治療慢性阻塞性肺疾病急性加重期痰熱阻肺證的機制[J]. 中西醫結合學報, 2008, 6(8):799-805.
11.	張穎, 李廷謙, 王剛, 等. 痰熱清注射液治療慢性阻塞性肺病急性加重期(痰熱阻肺證)的隨機對照試驗[J]. 中國循證醫學雜志, 2004, 4(5):300-305.
12.	Bhowmik A, Seemungal TA, Sapsford R J, et al. Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbation[J]. Thorax, 2000, 55(2):114-120.
13.	Takanashi S, Hasegawa Y, Kanehira Y, et al. Interleukin-10 level in sputum is reduced in bronchial asthmas, COPD and in smokes[J]. Eur Respir J, 1999, 14(2):309-314.
14.	Hubbard R, Tattersfield A. Inhaled corticosteroids, bone mineral density and fracture in older people[J]. Drugs Aging, 2004, 21(10):631-638.
15.	Mannion BA, Weiss J, Elsbach P. Separation of sublethal and lethal effects of polymorphonuclear leukocytes on Escherichia coli[J]. J Clin Invest, 1990, 86(2):631-641.
16.	Mannion BA, Weiss J, Elsbach P. Separation of sublethal and lethal effects of the bactericidal/permeability increasing protein on Escherichia coli[J]. J Clin Invest, 1990, 85(3):853-860.
17.	楊艷娟, 程德云, 李熙霞, 等. 慢性阻塞性肺疾病急性加重期病原菌檢出情況與病情評估[J]. 四川大學學報:醫學版, 2007, 38(4):742-744.
18.	李婷, 闞全程, 余祖江. 巢式PCR檢測慢性支氣管炎患者外周血BPI mRNA的表達水平[J]. 醫藥論壇雜志, 2007, 28(22):13-15.

1. Lopez AD, Murray CC. The global burden of disease, 1990-2020[J]. Nature Med, 1998, 4(11):1241-1243.
2. World Health Organization. The global burden of disease:2004 update[R/OL].[2015-02-01]. http://www.who.int/healthinfo/global_burden_disease/2004_report_update/en/.
3. Fuhrman C, Delmas MC. Epidemiology of chronic obstructive pulmonary disease in France[J]. Rev Mal Respir, 2010, 27(2):160-168.
4. Caballero A, Torres-Duque CA, Jaramillo C. Prevalence of COPD in five Colombian cities situated at low, medium, and high altitude (PREPOCOL study)[J]. Chest, 2008, 133(2):343-349.
5. Greskevitch M, Kullman G, Bang KM. Respiratory disease in agricultural workers:mortality and morbidity statistics[J]. J Agromedicine, 2008, 12(3):5-10.
6. Halbert RJ, Natoli JL, Gano A, et al. Global burden of COPD:systematic review and meta-analysis[J]. Eur Respir J, 2006, 28(3):523-532.
7. Vestbo J, Hurd SS, Agustí AG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease:GOLD executive summary[J]. Am J Respir Crit Care Med, 2013, 187(4):347-65.
8. 中華醫學會呼吸病學分會. 慢性阻塞性肺疾病診治指南(2007年修訂版)[J]. 中華結核與呼吸雜志, 2007, 30(1):8-17.
9. 鄭筱萸. 中藥新藥臨床研究指導原則(試行)[M]. 北京:中國醫藥科技出版社, 2002:54-58.
10. 李文, 毛兵, 王剛, 等. 從氣道炎癥和氣道黏液高分泌泌研究清熱化痰法治療慢性阻塞性肺疾病急性加重期痰熱阻肺證的機制[J]. 中西醫結合學報, 2008, 6(8):799-805.
11. 張穎, 李廷謙, 王剛, 等. 痰熱清注射液治療慢性阻塞性肺病急性加重期(痰熱阻肺證)的隨機對照試驗[J]. 中國循證醫學雜志, 2004, 4(5):300-305.
12. Bhowmik A, Seemungal TA, Sapsford R J, et al. Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbation[J]. Thorax, 2000, 55(2):114-120.
13. Takanashi S, Hasegawa Y, Kanehira Y, et al. Interleukin-10 level in sputum is reduced in bronchial asthmas, COPD and in smokes[J]. Eur Respir J, 1999, 14(2):309-314.
14. Hubbard R, Tattersfield A. Inhaled corticosteroids, bone mineral density and fracture in older people[J]. Drugs Aging, 2004, 21(10):631-638.
15. Mannion BA, Weiss J, Elsbach P. Separation of sublethal and lethal effects of polymorphonuclear leukocytes on Escherichia coli[J]. J Clin Invest, 1990, 86(2):631-641.
16. Mannion BA, Weiss J, Elsbach P. Separation of sublethal and lethal effects of the bactericidal/permeability increasing protein on Escherichia coli[J]. J Clin Invest, 1990, 85(3):853-860.
17. 楊艷娟, 程德云, 李熙霞, 等. 慢性阻塞性肺疾病急性加重期病原菌檢出情況與病情評估[J]. 四川大學學報:醫學版, 2007, 38(4):742-744.
18. 李婷, 闞全程, 余祖江. 巢式PCR檢測慢性支氣管炎患者外周血BPI mRNA的表達水平[J]. 醫藥論壇雜志, 2007, 28(22):13-15.

West China Medical Journal

Clinical Effect and Mechanism of Heat-clearing and Phlegm-resolving Recipe in the Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease (Phlegm Heat and Phlegm Turbidity in Lungs)

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content